-
Product Insights
NewLikelihood of Approval Analysis for Glaucoma
Overview How likely is it that the drugs in Glaucoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Glaucoma Overview Glaucoma is a disease of the eye in which fluid pressure...
-
Product Insights
NewLikelihood of Approval Analysis for Hyperlipidemia
Overview How likely is it that the drugs in Hyperlipidemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hyperlipidemia Overview Hyperlipidemia is a medical condition characterized by elevated levels of lipids...
-
Product Insights
NewLikelihood of Approval Analysis for Hypertension
Overview How likely is it that the drugs in Hypertension will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypertension Overview Hypertension, commonly known as high blood pressure, is a chronic medical...
-
Product Insights
NewNet Present Value Model: Elevation Oncology Inc’s Seribantumab
Empower your strategies with our Net Present Value Model: Elevation Oncology Inc's Seribantumab report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval Analysis for Pituitary Gland Disorders
Overview How likely is it that the drugs in Pituitary Gland Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pituitary Gland Disorders Overview Pituitary gland disorders involve dysregulation of the...
-
Analyst Opinions
Cocktail Culture – Industry Insights, Consumer Drivers, Brand Challenges and Innovation Landscape
Cocktail Culture Industry Report Overview The cocktail culture is a historic trend that has undergone several movements over the decades. In the 21st century, it has benefited from the craft alcohol movement and demand for premium experiences.  In 2024, cocktail culture has been influenced by relatively recent developments such as the craft craze, COVID's elevation of home-based indulgence and entertaining, increased RTD product diversity and sophistication, and the emergence of a more experiential-focused Gen Z consumer base. The ‘Cocktail Culture...
-
Analyst Opinions
Top Trends in Household Care and Laundry – Industry Insights
Top Trends in Household Care and Laundry Report Overview The household care and laundry industry is valued at $32.75 billion in 2024 and will grow at a CAGR of more than 2% during 2023–27. Elevated costs continue to influence purchasing habits and inhibit the volume growth in the industry. Demand for private labels and cheaper products is likely to increase as consumers look to stretch budgets further. Trends in Household Care and Laundry Report Outlook, 2023-2027 ($Billion) Buy the Full...
-
Product Insights
NewLikelihood of Approval Analysis for Open-Angle Glaucoma
Overview How likely is it that the drugs in Open-Angle Glaucoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Open-Angle Glaucoma Overview Open-angle glaucoma is a chronic eye condition characterized by...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Staphylokinase in Pulmonary Embolism
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Staphylokinase in Pulmonary Embolism report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Staphylokinase in Pulmonary Embolism Drug Details: Staphylokinase (fortelyzin) is an enzyme secreted...
-
Analyst Opinions
Dairy and Dairy Alternative Demand Spaces – Top Trends and Industry Insights
Reasons to buy the ‘Dairy and Dairy Alternative Demand Spaces’ report: Understand consumer attitudes and behaviors based on the "five Ws": the who, what, when, where, and whys. Explore and identify how to leverage the top trends in dairy and alternatives in 2024. Gain insight into how competitors and the innovation landscape are responding to this trend. Access valuable strategic take-outs to help direct future decision-making and inform new product and service development. How is our ‘Dairy and Dairy Alternative...